John E Leonard

Title: John E Leonard: Innovator in Antibody Therapeutics

Introduction

John E Leonard is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of antibody therapeutics, holding a total of 2 patents. His work focuses on innovative methods for treating B cell-related conditions.

Latest Patents

Leonard's latest patents include the "Expression and use of anti-CD20 Antibodies." This patent discloses methods for depleting peripheral blood B cells in a human host through the administration of an immunologically active anti-CD20 antibody. The patent emphasizes the effectiveness of this approach in treating various conditions. Another notable patent is the "Radiolabeling method," which details antibody binding assays and radiolabeling kits designed for testing therapeutic antibodies in commercial settings. These kits are specifically tailored for creating and evaluating radiolabeled anti-CD20 conjugates, which are essential for the treatment and imaging of B cell lymphoma tumors. The kits ensure high levels of antibody radiolabeling and product stability, yielding highly reproducible results.

Career Highlights

Throughout his career, Leonard has worked with notable companies such as Biogen Idec, Inc. and Rit Oncology, LLC. His experience in these organizations has allowed him to develop and refine his innovative approaches to antibody therapeutics.

Collaborations

Leonard has collaborated with esteemed colleagues, including Darrell R Anderson and Nabil Hanna. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

John E Leonard is a distinguished inventor whose work in antibody therapeutics has led to significant advancements in the treatment of B cell-related conditions. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.